QingSong Health Corporation (QingSong Health) filed its Monthly Return for Equity Issuers for the period ended 31 March 2026, indicating a stable share structure and continued adherence to Hong Kong Stock Exchange (HKEX) listing requirements.
Authorised and Issued Share Capital • Authorised share capital remained unchanged at 500.00 million ordinary shares with a par value of USD 0.0001, totalling USD 50,000. • Issued share capital closed the month at 206.37 million shares, identical to the prior month. No treasury shares were held or transacted.
Public Float Status • QingSong Health confirmed compliance with HKEX’s minimum public float requirement of 25% of issued shares (excluding treasury shares).
Equity Incentive Plans • The Pre-IPO Share Option Scheme (“2015/2017 Share Plan”) maintained 28.09 million outstanding options. • No options were granted, exercised, cancelled, or lapsed during March, and no new shares were issued under the plan. • The latest grant was on 3 December 2025; these options remain exercisable until 2 December 2035.
Capital Movements and Instruments • The company reported no warrants, convertible securities, other share-issuance agreements, or treasury share movements during the month.
Governance Confirmation • The filing, signed by Joint Company Secretary Yang Lei, affirms that all regulatory and listing rule obligations were met for the period under review.
Overall, QingSong Health’s March 2026 return highlights capital stability and regulatory compliance, with no dilution or treasury share activity recorded during the month.
Comments